Traub Capital Management LLC Takes $193,000 Position in Lam Research Corporation $LRCX

Traub Capital Management LLC purchased a new stake in shares of Lam Research Corporation (NASDAQ:LRCX) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 1,986 shares of the semiconductor company’s stock, valued at approximately $193,000.

Several other institutional investors and hedge funds also recently bought and sold shares of LRCX. Empowered Funds LLC raised its stake in shares of Lam Research by 10.5% during the 1st quarter. Empowered Funds LLC now owns 187,472 shares of the semiconductor company’s stock worth $13,629,000 after purchasing an additional 17,833 shares in the last quarter. Sava Infond d.o.o. raised its position in Lam Research by 3.1% during the second quarter. Sava Infond d.o.o. now owns 75,250 shares of the semiconductor company’s stock valued at $7,325,000 after acquiring an additional 2,250 shares in the last quarter. Genus Capital Management Inc. acquired a new stake in Lam Research in the second quarter valued at approximately $14,476,000. Cookson Peirce & Co. Inc. bought a new stake in Lam Research in the first quarter worth approximately $607,000. Finally, Glass Wealth Management Co LLC increased its stake in shares of Lam Research by 8.5% during the 2nd quarter. Glass Wealth Management Co LLC now owns 28,870 shares of the semiconductor company’s stock worth $2,810,000 after purchasing an additional 2,270 shares during the last quarter. Hedge funds and other institutional investors own 84.61% of the company’s stock.

Lam Research Stock Up 3.9%

LRCX opened at $148.80 on Thursday. The business has a 50 day moving average of $143.18 and a 200-day moving average of $111.22. The stock has a market capitalization of $186.90 billion, a price-to-earnings ratio of 32.78, a P/E/G ratio of 1.68 and a beta of 1.87. The company has a current ratio of 2.21, a quick ratio of 1.60 and a debt-to-equity ratio of 0.37. Lam Research Corporation has a 1-year low of $56.32 and a 1-year high of $167.15.

Lam Research (NASDAQ:LRCX) last released its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 EPS for the quarter, beating the consensus estimate of $1.22 by $0.04. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The firm had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.23 billion. During the same period in the prior year, the company earned $0.86 EPS. The business’s quarterly revenue was up 27.7% compared to the same quarter last year. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. As a group, sell-side analysts anticipate that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd will be given a dividend of $0.26 per share. The ex-dividend date is Wednesday, December 3rd. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.7%. Lam Research’s payout ratio is currently 22.91%.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on LRCX shares. BNP Paribas Exane lifted their price objective on shares of Lam Research from $80.00 to $140.00 and gave the company a “neutral” rating in a research note on Thursday, October 23rd. Susquehanna upped their price target on Lam Research from $135.00 to $200.00 and gave the stock a “positive” rating in a research note on Thursday, October 23rd. Wells Fargo & Company raised their price objective on Lam Research from $135.00 to $145.00 and gave the company an “equal weight” rating in a research note on Thursday, October 23rd. New Street Research upped their target price on Lam Research from $105.00 to $140.00 and gave the stock a “neutral” rating in a research report on Thursday, October 23rd. Finally, Raymond James Financial increased their price target on Lam Research from $90.00 to $110.00 and gave the company an “outperform” rating in a report on Thursday, July 31st. One analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and nine have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $149.04.

Insider Transactions at Lam Research

In other Lam Research news, insider Ava Harter sold 9,010 shares of Lam Research stock in a transaction on Monday, October 27th. The shares were sold at an average price of $157.47, for a total transaction of $1,418,804.70. Following the sale, the insider owned 56,786 shares in the company, valued at $8,942,091.42. The trade was a 13.69% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Douglas R. Bettinger sold 40,080 shares of the firm’s stock in a transaction dated Friday, November 14th. The stock was sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the transaction, the chief financial officer directly owned 987,237 shares of the company’s stock, valued at $148,677,892.20. The trade was a 3.90% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 102,608 shares of company stock valued at $14,916,496. Company insiders own 0.31% of the company’s stock.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.